Evaluation of Apoptotic Molecular Markers in Myelodysplastic Syndrome Patients

Blood- United States

doi 10.1182/blood.v112.11.5094.5094

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society of Hematology

Related search

Prognostic Markers of Efficiency of Immunosupressive Therapy in Patients With Myelodysplastic Syndrome

ScienceRise
2015English

A Retrospective Evaluation of Patients With Myelodysplastic Syndrome

Experimental Biomedical Research
2019English

Elderly Gastric Cancer Patients With Myelodysplastic Syndrome

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2018English

Unclassified Myelodysplastic Syndrome

2020English

Patterns of Blood Product Use Among Patients With Myelodysplastic Syndrome

Vox Sanguinis
MedicineHematology
2011English

Incidence of Myelodysplastic Syndrome in Japan

Journal of Epidemiology
MedicineEpidemiology
2014English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

Relationship Between Rac1 Levels and Neutrophil Counts in Myelodysplastic Syndrome Patients

Integrative Clinical Medicine
2018English

Myelodysplastic Syndrome Over Time

Mayo Clinic Proceedings
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy